Rhythmic Handwriting Deficits and General Rhythmic Abilities in Children
Launched by UNIVERSITY HOSPITAL, MONTPELLIER · Aug 17, 2023
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how children with Developmental Coordination Disorder (DCD) experience difficulties with rhythm, particularly in tasks like handwriting and music. DCD is a condition that affects motor skills, making it hard for some kids to coordinate their movements. Researchers want to understand if these rhythm challenges in handwriting and other activities are linked and if they come from the same underlying issue in the brain. If they find a connection, it could lead to new therapies that help improve these skills through fun activities, like games.
To participate in this study, children must be between the ages of 7 and 10, be able to read and write, and have a diagnosis of DCD. They should be native French speakers and live with at least one parent. During the trial, children will take part in activities that help researchers learn more about their rhythmic abilities. It's important to mention that children with certain other conditions, like serious visual impairments or neurological disorders, won't be eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children aged 7 to 10 inclusive
- • Children who can read and write
- • Diagnosis of DCD according to DSM-5 criteria (APA, 2015)
- • Native French speaker
- • Living with at least one parent
- Exclusion Criteria:
- • Intellectual development disorder confirmed or suspected during the initial evaluation phase in the MPEA department.
- • Presence or suspected presence of a visual impairment at the root of the motor skills deficit.
- • Presence or suspected presence of a neurological motor disorder (e.g. sensory impairment, cerebral palsy, muscular dystrophy, degenerative disease).
- • Not affiliated to a social security scheme or not benefiting from such a scheme.
- • Absence of written, informed consent from parents.
About University Hospital, Montpellier
The University Hospital of Montpellier is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its commitment to patient-centered care, the hospital collaborates with multidisciplinary teams to explore cutting-edge treatments and therapies across various medical fields. By integrating clinical practice with education and research, the University Hospital of Montpellier aims to enhance health outcomes and contribute to the scientific community's understanding of complex medical conditions. Its robust infrastructure and expertise make it a pivotal player in the landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montpellier, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported